Neurology and Neurosurgery - Global Neurology Academy

225-240 of 546

Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiers
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
Kaitlin Batley, MD
- Kaitlin Batley, MD
Optimizing DMD Care Through Multidisciplinary Collaboration
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiers
Optimizing DMD Care Through Multidisciplinary Collaboration
Kaitlin Batley, MD
- Kaitlin Batley, MD
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiers
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Christopher A. Scheiner, MD, PhD
- Christopher A. Scheiner, MD, PhD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiers
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Managing MS in Older Adults: Top 5 Clinical Considerations
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
Yinan Zhang, MD
- Yinan Zhang, MD
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Global Neurology Academy
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Chafic Karam, MD; Ryan Quigley
- Chafic Karam, MD
- Ryan Quigley
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Global Neurology Academy
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Danielle Minetti; Ryan Quigley
- Danielle Minetti
- Ryan Quigley
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiers
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Richard Nowak, MD, MS
- Richard Nowak, MD, MS
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
John A. Morren, MD, FAAN, FAANEM
- John A. Morren, MD, FAAN, FAANEM
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiers
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
Riley Bove, MD, MMSc
- Riley Bove, MD, MMSc
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiers
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
Riley Bove, MD, MMSc
- Riley Bove, MD, MMSc
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
NeuroFrontiers
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
Ahmed Abdelhak, MD
- Ahmed Abdelhak, MD
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiers
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
Mary Rensel, MD, FAAN, ABIHM
- Mary Rensel, MD, FAAN, ABIHM
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Debunking gMG Myths: Counseling Strategies That Change the Conversation
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiers
Debunking gMG Myths: Counseling Strategies That Change the Conversation
Maxwell H. Levy, MD
- Maxwell H. Levy, MD

15/11